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Abstract
Background: Ewing sarcomas are highly aggressive malignant tumours occurring predominantly in the long bones
of the extremities in children and young adults. About 20 % of patients will present with metastases at diagnosis
with the commonest sites being the lungs, bone and bone marrow. Cases of primary small bowel Ewing sarcomas
have been described but are nonetheless exceedingly rare, even more so cases of metastasis to the small bowel.
Case Presentation: We describe a case of vertebral Ewing sarcoma in a 44 year-old female which metastasized to
the jejunum causing intussusception.
Conclusions: Ewing’s sarcoma is highly aggressive and presence of metastases, overt or subclinical, is thought to
be present in almost all patients at diagnosis. As evidenced by our patient, metastatic disease can progress rapidly
to cause further complications and confer a poorer survival. The possibility of metastasis, no matter how rare or
unlikely the site is, should be considered and actively investigated to expedite treatment of the primary disease.
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Background
Ewing sarcomas are rare small round cell tumours that
arise predominantly in children and young adults with a
slight male predilection [1, 4, 7]. Ewing sarcoma most
often arises in the mid-shaft or diaphysis of the long
bones of the extremities with the spine making up 8 %
of primary sites [2]. Approximately, 80 % of patients
present with clinically localized disease although it is
surmised that subclinical metastatic disease is present in
almost all patients due to high relapse rates of 80 to
90 % in patients undergoing local therapy alone [3]. Me-
tastases are mostly found in the lungs, bone and bone
marrow [4]. Eight cases of primary small bowel Ewing
sarcoma have been reported [8–10, 14]. One such case
occurred in an 18-year-old male which was complicated
by intussusception as well [9]. Reports of metastasis of
Ewing sarcoma to the small bowel are even fewer and
far between. Capitini reported a case of left femur Ewing
sarcoma metastasizing to the brain and small intestine
after allogenic stem cell transplantation [13].
Case presentation
A previously well 44-year-old female presented with
acute lower limb numbness and weakness of 1-day dur-
ation. Prior to this, she suffered from back pain for
2 weeks that gradually progressed to pain in both hips as
well. There were no complaints of urinary or bowel in-
continence. She did not experience any abdominal pain,
distension, vomiting or constipation.
On examination, the patient had decreased sensation
and power in the bilateral lower limbs and up-going
plantar reflexes. Abdominal examination revealed no
mass or distension. Bowel sounds were active. Anal tone
was intact on digital rectal examination.
Magnetic resonance imaging of her thoracic and lumbar
spine with 10 ml intravenous Magnevist showed abnormal
marrow replacement affecting the 11th thoracic vertebral
body associated with enhancement causing compression
of the spinal cord (Fig. 1). The initial impression was spine
metastases from unknown primary causing spinal cord
compression. The patient underwent excision of thoracic
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spine tumour, decompression laminectomy and fixation
the following day. A computed tomography (CT) scan of
her thorax and abdomen with 80 ml intravenous Omnipa-
que 350 was performed 2 days after surgery to look for a
primary malignancy. A 2-cm liver lesion (Fig. 2) was
detected along with an indeterminate 0.3-cm left pulmon-
ary nodule and a single enlarged 1.3-cm para-aortic lymph
node. The small and large bowels were normal (Fig. 3).
Immunohistology of the vertebral tumour revealed epi-
dural Ewing sarcoma. Molecular testing detected presence
of t(11;22)(q24;q12) translocation further confirming the
diagnosis of Ewing sarcoma.
The patient was planned for chemotherapy but, 3 weeks
after her spine surgery, she developed symptoms of intes-
tinal obstruction with persistent vomiting, intermittent
upper abdominal pain and distension. A repeat CT scan
showed multiple new lytic lesions in the vertebrae, right
iliac bone and right femur, increase in size and number of
liver nodules (Fig. 4) and para-aortic lymphadenopathy. It
also showed new findings of small bowel dilatation second-
ary to an entero-enteric intussusception (Fig. 5). An emer-
gent laparotomy was performed and jejunal-jejunal
intussusception was found (Fig. 6) with a 5-cm tumour
forming the lead point (Fig. 7). There were no other lesions
in the small bowel and colon. The affected segment of the
small bowel was resected with primary anastomosis. Histo-
pathological examination of the resected small bowel
tumour confirmed metastatic Ewing sarcoma, morpho-
logically similar to the spinal tumour (Figs. 8 and 9).The en-
tire panel of immunochemical stains including CD99,
Fig. 1 MRI spine showing abnormal enhancement of the thoracic
vertebra with spinal cord compression
Fig. 2 Liver metastatic nodule on initial CT
Fig. 3 Normal bowel on initial CT
Fig. 4 Increase in size of metastatic liver nodule on subsequent CT
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synaptophysin, chromogranin, MNF-116, AE1/AE3, epithe-
lial membrane antigen (EMA), CD34, HMB-45,desmin and
S100 showed similar results in both the vertebral as well as
the small bowel tumour (Figs. 10, 11, 12 and 13).
The patient made an uneventful recovery from surgery
and was started on palliative chemotherapy. She eventually
succumbed to progressive metastatic disease 16 months
after her initial diagnosis.
Discussion
The Ewing sarcoma family of tumors (ESFT) consists of
Ewing sarcoma, peripheral primitive neuroectodermal
tumor (PNET), extraosseous Ewing sarcoma (EES), and
Askin’s tumor (Ewing sarcoma of the chest wall). ESFT
tumours are of neural crest derivation that differentiate
along a neuroendocrine lineage and are described as
small round cell tumours. All ESFT tumours are char-
acterized by a balanced chromosomal translocation be-
tween the 5ʹ half of the EWS gene (22q12) and the 3ʹ
half of members of the ETS family of transcription fac-
tors, leading to the understanding that ESFT represents
a single neoplastic entity [5].
Ewing sarcoma predominantly affects children and
young adults with a peak incidence between 10 and
20 years of age. About 30 % occur in adults over the age
of 20 and fewer than 5 % occur in adults over the age of
40 [6]. Ewing sarcoma most often arises in the mid-shaft
or diaphysis of the long bones of the extremities with
the spine making up only 8 % of primary sites of Ewing
sarcoma [2]. Our patient, being a 44-year-old female
adult, did not fit the typical profile of an Ewing sarcoma
patient and was initially treated as spinal metastases
Fig. 5 New development of entero-enteric intussusception and
small bowel dilatation on subsequent CT
Fig. 6 Intra-operative findings of jejunal-jejunal intussusception
Fig. 7 Intraluminal mass forming pathologic lead point
Fig. 8 Characteristic sheets of small blue round cells from primary
vertebral Ewing sarcoma
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from a yet undetermined primary. It was only on histo-
pathological examination of the spinal tumour that the
diagnosis of Ewing sarcoma was reached.
The presence of metastasis is the single most import-
ant factor in determining survival in ESFT patients. Pa-
tients with metastatic disease at diagnosis have a dismal
5-year survival rate varying from 0–25 %, compared with
40–79 % for those with localized disease [5, 7]. Chemo-
therapy is essential in the treatment of Ewing sarcoma
because although approximately 80 % of patients present
with clinically localized disease, subclinical metastatic
disease is presumed to be present in almost all patients
due to a 80–90 % relapse rate noted in patients who
underwent local therapy alone [3]. It is possible that our
patient had occult metastases that continued to rapidly
progress after excision of the primary tumour before
commencement of systemic chemotherapy. Metastases
are mostly found in the lungs (50 %), bone (25 %) and
bone marrow (20 %) [4]. Only eight cases of primary
Ewing sarcoma of the small bowel have been reported
[8–10, 14, 15], and metastasis of Ewing sarcoma to the
small bowel is even rarer with Capitini reporting a case
of a 26-year-old male with metastasis of left femur
Ewing sarcoma to the small bowel and brain following
allogenic stem cell transplantation.
Intussusception is the invagination of a bowel loop
with its mesenteric fold (intussusceptum) into the
lumen of a contiguous portion of the bowel (intussusci-
piens) as a result of peristalsis. Intussusception is rare
in adults, accounting for 1–5 % of all cases of intestinal
obstruction and 5 % of all intussusceptions [11]. Most
cases of intussusception in adults are due to a patho-
logic lead point within the bowel and are malignant in
over 50 % of cases [12], thereby necessitating surgery
and resection of the affected bowel segment. In the
Fig. 9 Histomorphologically similar round cells from small bowel
metastatic tumour
Fig. 10 Positive cell membrane reactivity for CD99 from primary
vertebral Ewing sarcoma
Fig. 11 Positive CD99 staining from small bowel metastatic tumour
Fig. 12 Positive staining for neuroendocrine marker synaptophysin
in primary vertebral Ewing sarcoma
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small intestine, an intussusception can be secondary to
the presence of intra- or extra-luminal lesions which
include inflammatory lesions, Meckel’s diverticulum,
postoperative adhesions, lipoma, adenomatous polyps,
lymphoma and metastases or iatrogenic (the presence of
an intestinal tube, in patients with a gastrojejunostomy,
etc.). Malignancy (adenocarcinoma) accounts for up to
30 % of cases of intussusception occurring in the small
bowel [11]. In 2003, Boehm [9] described a case of
ileoileal intussusception in an 18-year-old male who
presented with a protracted course of abdominal pain
and vomiting for several weeks. The intussusception
was eventually discovered on laparotomy and histo-
pathology of the resected bowel revealed primary Ewing
sarcoma. Our patient suffered from intussusception as
well, although the cause was due to a large jejunal
intraluminal metastasis from her primary spinal ES. No
bowel mass was evident on her initial CT scan (Figs. 3
and 14), but her subsequent CT performed after develop-
ment of intestinal obstructive symptoms showed not only
new development of small bowel intussusception but also
progression of metastatic disease (Figs. 4, 5 and 15). The
resected jejunal metastatic tumour, possibly a result of
haematogenous spread, displayed the same histomorpho-
logical and immunohistochemical characteristics as the
vertebral primary tumour (Figs. 8, 9, 10, 11, 12 and 13).
Conclusions
Ewing’s sarcoma is a highly aggressive small round cell
tumour that rarely arises in adults. The presence of metas-
tases, overt or subclinical, is thought to be present in al-
most all patients at diagnosis and, as evidenced by our
patient, can progress rapidly to cause further complications
and confer a poorer survival. The possibility of metastasis,
no matter how rare or unlikely the site is, should be con-
sidered and actively investigated to expedite treatment of
the primary disease.
Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Fig. 13 Positivity of neural marker synaptophysin in small bowel
metastatic tumour
Fig. 14 Initial coronal CT showing normal appearance of bowel and
liver metastasis
Fig. 15 Subsequent coronal CT showing new entero-enteric intus-
susception and enlargement of liver metastasis
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